Problems in the management of attention-deficit-hyperactivity disorder

New England Journal of Medicine

Volumn 340, Issue 1, 1999, Pages 40-46

  Zametkin, Alan J ^a,b   Ernst, Monique ^c  

^a NATIONAL INSTITUTE OF MENTAL HEALTH   (United States)

^b NATIONAL INSTITUTES OF HEALTH   (United States)

^c NONE

Author keywords

[No Author keywords available]

Indexed keywords

CENTRAL STIMULANT AGENT; DEXAMPHETAMINE; METHYLPHENIDATE;

ATTENTION DEFICIT DISORDER; BEHAVIOR MODIFICATION; CLINICAL FEATURE; COUNSELING; DIAGNOSTIC APPROACH ROUTE; DIFFERENTIAL DIAGNOSIS; DISEASE CLASSIFICATION; HUMAN; MEDICAL ASSESSMENT; PRIORITY JOURNAL; PSYCHOSOCIAL CARE; RATING SCALE; REVIEW;

ADULT; ATTENTION DEFICIT DISORDER WITH HYPERACTIVITY; BEHAVIOR THERAPY; CENTRAL NERVOUS SYSTEM STIMULANTS; CHILD; DIAGNOSIS, DIFFERENTIAL; FEMALE; HUMANS; MALE;

EID: 0033531085     PISSN: 00284793     EISSN: None     Source Type: Journal    
DOI: 10.1056/NEJM199901073400107     Document Type: Review

References (39)

1. Szatmari P. The epidemiology of attention deficit hyperactivity disorder. Child Adolesc Psychiatr Clin North Am 1992;1:361-71.
2. Wolraich ML, Hannah JN, Pinnock TY, Baumgaertel A, Brown J. Comparison of diagnostic criteria for attention-deficit hyperactivity disorder in a county-wide sample. J Am Acad Child Adolesc Psychiatry 1996; 35:319-24.
3. Ernst M. Neuroimaging in attention-deficit/hyperactivity disorder. In: Lyon GR, Rumsey JM, eds. Neuroimaging, a window to the neurological foundations of learning and behavior in children. Baltimore: Paul H. Brookes Publishing, 1996:95-117.
4. Silberg J, Rutter M, Meyer J, et al. Genetic and environmental influences on the covariation between hyperactivity and conduct disturbance in juvenile twins. J Clin Psychol Psychiatry 1996;37:803-16.
5. Kolata G. Boom in ritalin sales raises ethical issues. New York Times. May 15, 1996:C8.
6. Safer DJ, Zito JM, Fine EM. Increased methylphenidate usage for attention deficit disorder in the 1990s. Pediatrics 1996;98:1084-8.
7. American Psychiatric Association. Diagnostic and statistical manual of mental disorders, 4th ed.: DSM-IV. Washington, D.C.: American Psychiatric Association, 1994:78-85.
8. Lahey BB, Pelham WE, Stein MA, et al. Validity of DSM-TV attention-deficit/hyperactivity disorder for younger children. J Am Acad Child Adolesc Psychiatry 1998;37:695-702.
9. Biederman J, Faraone SV, Keenan K, et al. Further evidence for family-genetic risk factors in attention deficit hyperactivity disorder: patterns of comorbidity in probands and relatives in psychiatrically and pediatrically referred samples. Arch Gen Psychiatry 1992;49:728-38.
10. Barkley RA, ed. Attention deficit hyperactivity disorder: a handbook for diagnosis and treatment. New York: Guilford Press, 1990:252, 278-324.
11. Idem. Sex differences in ADHD. Vol. 3. No. 1. The ADHD Report 1995:1-4. (New York: Guilford Press.)
12. Practice parameters for the assessment and treatment of children, adolescents, and adults with attention-deficit/hyperactivity disorder. J Am Acad Child Adolesc Psychiatry 1997;36:Suppl:85S-121S.
13. Hauser P, Zametkin AJ, Martinez P, et al. Attention deficit-hyperactivity disorder in people with generalized resistance to thyroid hormone. N Engl J Med 1993;328:997-1001.
14. Cantwell DP. Attention deficit disorder: a review of the past 10 years. J Am Acad Child Adolesc Psychiatry 1996;35:978-87.
15. Connors CK, Wells KC, Erhardt D, et al. Multimodal therapies: methodologic issues in research and practice. Child Adolesc Psychiatr Clin North Am 1994;3:361-77.
16. Arnold LE, Abikoff HB, Cantwell DP, et al. National Institute of Mental Health Collaborative Multimodal Treatment Study of Children with ADHD (the MTA): design challenges and choices. Arch Gen Psychiatry 1997;54:865-70.
17. Shaywitz SE. Dyslexia. N Engl J Med 1998;338:307-12.
18. Abikoff H. Cognitive training in ADHD children: less to it than meets the eye. J Learn Disabil 1991;24:205-9.
19. Swanson JM, McBurnett K, Wigal T, et al. Effect of stimulant medication on children with attention deficit disorder: a "review of reviews." Except Child 1993;60:154-62.
20. Whalen CK, Henker BP. Psychostimulants and children: a review and analysis. Psychol Bull 1976;83:1113-30.
21. Barkley RA. A review of stimulant drug research with hyperactive children. J Child Psychol Psychiatry 1977;18:137-65.
22. Adelman HS, Compas BE. Stimulant drugs and learning problems. J Spec Educ 1977;11:377-416.
23. Carlson CL, Bunner MR. Effects of methylphenidate on the academic performance of children with attention-deficit hyperactivity disorder and learning disabilities. Sch Psychol Rev 1993;22:184-98.
24. Hinshaw SP. Stimulant medication and the treatment of aggression in children with attentional deficits. J Clin Child Psychol 1991;20:301-12.
25. Greenhill LL. Attention-deficit hyperactivity disorder: the stimulants. Child Adolesc Psychiatr Clin North Am 1995;4:123-68.
26. Rapport MD, Denney C, DuPaul GJ, Gardner MJ. Attention deficit disorder and methylphenidate: normalization rates, clinical effectiveness, and response prediction in 76 children. J Am Acad Child Adolesc Psychiatry 1994;33:882-93.
27. Barkley RA, Biederman J. Toward a broader definition of the age-of-onset criterion for attention-deficit hyperactivity disorder. J Am Acad Child Adolesc Psychiatry 1997;36:1204-10.
28. Spencer T, Biederman J, Wilens T, Harding M, O'Donnell D, Griffin S. Pharmacotherapy of attention-deficit hyperactivity disorder across the life cycle. J Am Acad Child Adolesc Psychiatry 1996;35:409-32.
29. Wilens TE, Biederman J, Mick E, Spencer TJ. A systematic assessment of tricyclic antidepressants in the treatment of adult attention-deficit hyperactivity disorder. J Nerv Ment Dis 1995;183:48-50.
30. Hechtman L. Adolescent outcome of hyperactive children treated with stimulants in childhood: a review. Psychopharmacol Bull 1985;21:178-91.
31. Wilens TE, Biederman J, Spencer TJ, Frances RJ. Comorbidity of attention-deficit hyperactivity and psychoactive substance use disorders. Hosp Community Psychiatry 1994;45:421-3, 435.
32. Loney J, Kramer JR, Salisbury H. Medicated versus unmedicated ADHD children as adults: attitudes about stimulant treatment and involvement with legal and illegal substances. Presented at the NIH Consensus Development Conference on Diagnosis and Treatment of Attention Deficit Hyperactivity Disorder, Bethesda, Md., November 16, 1998.
33. Walkup JT. Stimulant treatment of attention deficit hyperactivity disorder in children and adolescents with Tourette disorder. Vol. 25. No. 1. Newsletter of the Journal of the American Academy of Child and Adolescent Psychiatry 1994:248-50. (Washington, D.C.: American Academy of Child and Adolescent Psychiatry.)
34. Satterfield JH, Schell A. A prospective study of hyperactive boys with conduct problems and normal boys: adolescent and adult criminality. J Am Acad Child Adolesc Psychiatry 1997;12:1726-35.
35. Ingersoll BD, Goldstein S. Attention deficit disorder and learning disabilities: realities, myths, and controversial treatments. New York: Doubleday, 1993.
36. Silver LB. Controversial approaches to treating learning disabilities and attention deficit disorder. Am J Dis Child 1986;140:1045-52.
37. LaHoste GJ, Swanson JM, Wigal SB, et al. Dopamine D4 receptor gene polymorphism is associated with attention deficit hyperactivity disorder. Mol Psychiatry 1996;2:121-4.
38. Cook EH, Stein MA, Krasowski MD, et al. Association of attention-deficit disorder and the dopamine transporter gene. Am J Hum Genet 1995;56:993-8.
39. Gill M, Daly G, Heron S, Hawi Z, Fitzgerald M. Confirmation of association between attention deficit hyperactivity disorder and a dopamine transporter polymorphism. Mol Psychiatry 1997;2:311-3.